Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH. van der Meer P, et al. Among authors: van de wal rm, van gilst wh, van veldhuisen dj. Circulation. 2005 Sep 20;112(12):1743-7. doi: 10.1161/CIRCULATIONAHA.105.549121. Circulation. 2005. PMID: 16172283
High prevalence of microalbuminuria in chronic heart failure patients.
van de Wal RM, Asselbergs FW, Plokker HW, Smilde TD, Lok D, van Veldhuisen DJ, van Gilst WH, Voors AA. van de Wal RM, et al. Among authors: van gilst wh, van veldhuisen dj. J Card Fail. 2005 Oct;11(8):602-6. doi: 10.1016/j.cardfail.2005.05.007. J Card Fail. 2005. PMID: 16230263
New pharmacological strategies in chronic heart failure.
van de Wal RM, Voors AA, Plokker HW, van Gilst WH, van Veldhuisen DJ. van de Wal RM, et al. Among authors: van gilst wh, van veldhuisen dj. Cardiovasc Drugs Ther. 2004 Nov;18(6):491-501. doi: 10.1007/s10557-004-6227-x. Cardiovasc Drugs Ther. 2004. PMID: 15770437 Review.
Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.
van de Wal RM, Gansevoort RT, van der Harst P, Boomsma F, Thijs Plokker HW, van Veldhuisen DJ, de Jong PE, van Gilst WH, Voors AA. van de Wal RM, et al. Among authors: van gilst wh, van der harst p, de jong pe, van veldhuisen dj. Hypertension. 2006 Nov;48(5):870-6. doi: 10.1161/01.HYP.0000244082.26293.2d. Epub 2006 Sep 25. Hypertension. 2006. PMID: 17000930 Clinical Trial.
Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects.
van de Wal RM, van der Harst P, Gerritsen WB, van der Horst F, Plokker TH, Gansevoort RT, van Gilst WH, Voors AA. van de Wal RM, et al. J Renin Angiotensin Aldosterone Syst. 2007 Dec;8(4):177-80. doi: 10.3317/jraas.2007.029. J Renin Angiotensin Aldosterone Syst. 2007. PMID: 18205096 Free article. Clinical Trial.
Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction.
Hartog JW, van de Wal RM, Schalkwijk CG, Miyata T, Jaarsma W, Plokker HW, van Wijk LM, Smit AJ, van Veldhuisen DJ, Voors AA. Hartog JW, et al. Among authors: van de wal rm. Eur J Heart Fail. 2010 Apr;12(4):397-403. doi: 10.1093/eurjhf/hfq001. Epub 2010 Feb 12. Eur J Heart Fail. 2010. PMID: 20154337 Free article. Clinical Trial.
30 results